|
KIAA1704 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.66033853332692E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.26799714961612E-11 |
| Normal-vs-Stage2 |
8.15099998607849E-09 |
| Normal-vs-Stage3 |
3.9279690611238E-13 |
| Normal-vs-Stage4 |
5.78099790260467E-11 |
| Stage1-vs-Stage2 |
2.395600E-01 |
| Stage1-vs-Stage3 |
7.362000E-02 |
| Stage1-vs-Stage4 |
1.142420E-01 |
| Stage2-vs-Stage3 |
9.147800E-01 |
| Stage2-vs-Stage4 |
7.830600E-01 |
| Stage3-vs-Stage4 |
8.238400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
5.178000E-04 |
| Normal-vs-Asian |
1.398130E-03 |
| Caucasian-vs-AfricanAmerican |
1.287550E-01 |
| Caucasian-vs-Asian |
1.347620E-02 |
| AfricanAmerican-vs-Asian |
5.673000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.36002320516582E-13 |
| Normal-vs-Female |
3.39095418411262E-12 |
| Male-vs-Female |
7.686400E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.2582999631714E-09 |
| Normal-vs-Age(41-60Yrs) |
2.01394456667003E-13 |
| Normal-vs-Age(61-80Yrs) |
3.60644847319236E-12 |
| Normal-vs-Age(81-100Yrs) |
6.10269999999913E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.781800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.892200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.659420E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.324600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.746800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.662600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.051200E-01 |
| Classical-VS-Follicular |
1.297220E-01 |
| Classical-VS-Other |
3.806800E-01 |
| Classical-VS-Normal |
1.62649893553635E-11 |
| Tall-VS-Follicular |
8.204800E-01 |
| Tall-VS-Other |
8.271000E-01 |
| Tall-VS-Normal |
8.42120000399404E-08 |
| Follicular-VS-Other |
7.468000E-01 |
| Follicular-VS-Normal |
5.12149989084776E-10 |
| Other-VS-Normal |
1.141770E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.73780997872564E-13 |
| Normal-vs-N1 |
2.32260000121443E-08 |
| N0-vs-N1 |
9.044800E-01 |
|
|
